Page Loader Image
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
Public Pharma For Europe
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact

Leven van Erik (55) uit Oosterhesselen gered door experimenteel medicijn UMCG. ‘Kritiek farmalobby tenenkrommend’

Author: Arend van Wijngaarden

Date:  3/7/2025

Language: Dutch

Learn More: https://dvhn.nl/groningen/Erik-Holties%E2%80%99-55-leven-gered-door-experimenteel-medicijn-UMCG-%E2%80%98kritiek-farmalobby-tenenkrommend%E2%80%99-45774126.html

You might also enjoy

La política del medicamento en la UE y su renuncia a la salud global

Read More »

The European Pharmaceutical Package Agreement: an insufficient step that preserves industry privileges and fails to guarantee equitable access to medicines

Read More »

New $55 Insulin Pens Mark Step in California’s Fight Against Insulin Price Gouging

Read More »

The UK must defend drug price controls

Read More »

The pandemic accord: new possibilities for public health industrialisation pathways?

Read More »

Greed Is a Hell of a Drug

Read More »